PBS Website Update - 1 November 2022
Page last updated: 1 November 2022
The Schedule of Pharmaceutical Benefits was updated on 1 November 2022. New, Amended and Deleted items can be found on the Summary of Changes page.
The following updates have also been made to the PBS Website on the dates specified.
- Ex-manufacturer price - 1 November 2022
- Formulary Allocations - 1 November 2022
- Drugs subject to Price Disclosure - 1 November 2022
- Section 19A medicines subsidised by the Pharmaceutical Benefits Scheme - 1 November 2022
- Expanded access to COVID-19 oral antiviral treatments on the PBS - 1 November 2022
- Removal of the temporary PBS listings introduced during the tocilizumab shortage, which allowed patients to transition off tocilizumab and onto another biological disease modifying drug - 1 November 2022
- 1 November 2022 updates as part of the Digital Transformation of Authority Required (Written) PBS listings - 1 November 2022
- The Closing the Gap (CTG) - PBS Co-payment Program - 1 November 2022
- Medicine Status Website - 1 November 2022
- Drugs and manners of administration that meet the 42 month clock - 28 October 2022
- Drugs and manners of administration that meet the 30 month clock - 28 October 2022
- PBAC Public Summary Documents – July 2022 meeting - 28 November 2022
- Reference Committee for the Health Technology Assessment Policy and Methods Review - 27 October 2022
- Drug Utilisation Sub-Committee (DUSC) Utilisation Analysis Public Release Documents - 25 October 2022
- Designated Brands - 24 October 2022
- PBAC Cycle Timeframe for 2022 - 2023 - 21 October 2022
- Consultation on the revised PBS Post-market Review (PMR) Framework - 20 October 2022
- PBS and RPBS Section 85 Date of Supply Data - 13 October 2022
